| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
INVE-B.ST
|
410.20 | 745.1B | 4.73 | 0.78 | — | — | — | 86 | 76 | 1,230.60 | +148.0% | 87 | 0.12 |
|
SEB_A
|
219.20 | 422.0B | 3.39 | 1.90 | 2.08 | — | — | 82 | 61 | 515.51 | +100.0% | 86 | 5.20 |
|
SWED_A
|
376.50 | 423.1B | 3.39 | 2.04 | 4.53 | — | — | 79 | 51 | 731.71 | +69.8% | 85 | 5.47 |
|
SHB_A
|
147.20 | 286.3B | 3.01 | 1.58 | 5.90 | — | — | 76 | 46 | 295.08 | +64.3% | 68 | 9.24 |
|
NDA-FI.HE
|
17.25 | 59.0B | 12.25 | 1.82 | — | — | — | 70 | 59 | 24.45 | +30.9% | 88 | 6.37 |
|
KINV-B.ST
|
56.98 | 13.6B | — | 0.38 | — | — | — | 56 | 30 | 170.94 | +86.0% | 42 | 0.06 |
|
DNB.OL
|
308.70 | 442.5B | 13.68 | 17.63 | — | — | — | 51 | 44 | 184.30 | -25.8% | 99 | 3.51 |
|
DANSKE.CO
|
366.00 | 295.8B | 96.01 | 12.21 | — | — | — | 39 | 29 | 91.50 | -51.8% | 86 | 6.27 |
|
SHB-A.ST
|
147.20 | 291.5B | 100.00 | 15.68 | — | — | — | 39 | 27 | 36.80 | -51.8% | 85 | 8.46 |
|
SWED-A.ST
|
378.10 | 424.9B | 100.00 | 23.59 | — | — | — | 37 | 30 | 94.53 | -51.8% | 89 | 5.14 |
|
SEB-A.ST
|
220.00 | 431.5B | 100.00 | 20.10 | — | — | — | 36 | 28 | 55.00 | -51.8% | 88 | 3.67 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.